Skip to main content
. 2021 Nov-Dec;37(7):1959–1964. doi: 10.12669/pjms.37.7.4522

Table I.

Baseline characteristics of study participants (n=205).

Characteristics Frequency (n) Percentage (%)
Age in years (mean ± SD) 32.96±7.7
Age range 23 – 55
Gender Male 66 42.9%
Female 117 57.1%
Comorbidities Diabetes 23 11.2%
Hypertension 25 12.2%
Asthma 2 1.0%
Tested positive for COVID-19 Yes 40 19.5%
No 165 80.5%
Overall experienced symptoms Yes 60 29.3%
No 145 70.7%

In terms of post-vaccination symptoms, the distribution of acute side effects is presented in Fig.1.